Guizhou Yibai Pharmaceutical Co Ltd (600594) — Free Cash Flow Generation Index
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥26.20 Million represents 1% of operating cash flow (CN¥33.28 Million). Read Guizhou Yibai Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. Explore Guizhou Yibai Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Guizhou Yibai Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Guizhou Yibai Pharmaceutical Co Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | CN¥221.71 Million | CN¥256.71 Million | CN¥34.99 Million | ▲ +894.1% |
| 2024 | -0.11x | CN¥-9.45 Million | CN¥86.87 Million | CN¥96.32 Million | ▼ -116.6% |
| 2023 | 0.65x | CN¥247.23 Million | CN¥377.61 Million | CN¥130.38 Million | ▲ +910.4% |
| 2022 | 0.06x | CN¥22.38 Million | CN¥345.30 Million | CN¥322.92 Million | ▼ -87.6% |
| 2021 | 0.52x | CN¥486.43 Million | CN¥934.21 Million | CN¥447.78 Million | ▲ +756.5% |
| 2020 | -0.08x | CN¥-29.08 Million | CN¥366.66 Million | CN¥395.74 Million | ▼ -117.8% |
| 2019 | 0.45x | CN¥161.44 Million | CN¥362.71 Million | CN¥201.28 Million | ▲ +189.1% |
| 2018 | -0.50x | CN¥-107.03 Million | CN¥214.30 Million | CN¥321.33 Million | ▼ -222.1% |
| 2017 | 0.41x | CN¥278.98 Million | CN¥681.78 Million | CN¥402.80 Million | ▲ +223.9% |
| 2016 | 0.13x | CN¥48.08 Million | CN¥380.62 Million | CN¥332.53 Million | ▼ -74.6% |
| 2015 | 0.50x | CN¥285.66 Million | CN¥573.68 Million | CN¥288.02 Million | ▼ -20.1% |
| 2014 | 0.62x | CN¥337.65 Million | CN¥541.58 Million | CN¥203.94 Million | ▲ +18.5% |
| 2013 | 0.53x | CN¥303.76 Million | CN¥577.24 Million | CN¥273.48 Million | ▲ +93.4% |
| 2012 | 0.27x | CN¥78.37 Million | CN¥288.01 Million | CN¥209.64 Million | ▼ -44.2% |
| 2011 | 0.49x | CN¥135.49 Million | CN¥277.83 Million | CN¥142.34 Million | ▼ -14.5% |
| 2010 | 0.57x | CN¥66.01 Million | CN¥115.66 Million | CN¥49.66 Million | ▲ +0.0% |
| 2009 | 0.57x | CN¥59.26 Million | CN¥103.88 Million | CN¥44.62 Million | ▼ -14.6% |
| 2008 | 0.67x | CN¥126.40 Million | CN¥189.26 Million | CN¥62.86 Million | ▲ +129.5% |
| 2007 | -2.26x | CN¥-27.03 Million | CN¥11.94 Million | CN¥38.97 Million | ▼ -375.1% |
| 2006 | 0.82x | CN¥78.77 Million | CN¥95.77 Million | CN¥17.00 Million | ▲ +122.5% |
| 2005 | -3.66x | CN¥-63.60 Million | CN¥17.38 Million | CN¥80.99 Million | ▼ -335.6% |
| 2003 | -0.84x | CN¥-77.37 Million | CN¥92.10 Million | CN¥169.47 Million | ▼ -221.1% |
| 2002 | 0.69x | CN¥50.97 Million | CN¥73.46 Million | CN¥22.49 Million | — |